These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1438 related items for PubMed ID: 11331733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A, Bardach A, Rey Ares L, Glujovsky D, Cafferata ML, Cesaroni S, Bhatti A.
    Cochrane Database Syst Rev; 2019 Dec 05; 12(12):CD011260. PubMed ID: 31801180
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S, Shi J, Seib K, Lewis P, Moro PL, Woo EJ, Shimabukuro T, Orenstein WA.
    Lancet Infect Dis; 2015 Oct 05; 15(10):1175-1182. PubMed ID: 26289956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW.
    JAMA; 2004 Oct 13; 292(14):1696-701. PubMed ID: 15479934
    [Abstract] [Full Text] [Related]

  • 7. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Liu Y, Wang J, Liu S, Du J, Wang L, Gu W, Xu Y, Zuo S, Xu E, An Z.
    Vaccine; 2017 Mar 01; 35(9):1281-1286. PubMed ID: 28161421
    [Abstract] [Full Text] [Related]

  • 8. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA, Chilean IPV/bOPV study group.
    Lancet Infect Dis; 2015 Nov 01; 15(11):1273-82. PubMed ID: 26318714
    [Abstract] [Full Text] [Related]

  • 9. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Prevots DR, Burr RK, Sutter RW, Murphy TV, Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 2000 May 09; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
    [Abstract] [Full Text] [Related]

  • 10. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R, Li CG, Li Y, Liu Y, Zhao H, Chen X, Kuriyakose S, Van Der Meeren O, Hardt K, Hezareh M, Roy-Ghanta S.
    Vaccine; 2016 Mar 14; 34(12):1436-43. PubMed ID: 26873055
    [Abstract] [Full Text] [Related]

  • 11. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
    Zhao D, Ma R, Zhou T, Yang F, Wu J, Sun H, Liu F, Lu L, Li X, Zuo S, Yao W, Yin J.
    MMWR Morb Mortal Wkly Rep; 2017 Dec 15; 66(49):1357-1361. PubMed ID: 29240729
    [Abstract] [Full Text] [Related]

  • 12. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE, Eremeeva TP, Morozova NS, Shakaryan AK, Gmyl AP, Yakovenko ML, Korotkova EA, Chernjavskaja OP, Baykova OY, Silenova OV, Krasota AY, Krasnoproshina LI, Mustafina AN, Kozlovskaja LI.
    Vopr Virusol; 2016 Dec 15; 61(1):9-15. PubMed ID: 27145594
    [Abstract] [Full Text] [Related]

  • 13. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.
    MMWR Surveill Summ; 2003 Jan 24; 52(1):1-24. PubMed ID: 12825543
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.
    Miller MA, Sutter RW, Strebel PM, Hadler SC.
    JAMA; 1996 Sep 25; 276(12):967-71. PubMed ID: 8805731
    [Abstract] [Full Text] [Related]

  • 15. Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998-2014.
    Ivanova OE, Eremeeva TP, Morozova NS, Shakaryan AK, Korotkova EA, Kozlovskaya LI, Baykova OY, Krasota AY, Gmyl AP.
    Int J Infect Dis; 2018 Nov 25; 76():64-69. PubMed ID: 30201507
    [Abstract] [Full Text] [Related]

  • 16. Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1998 Dec 04; 47(47):1017-9. PubMed ID: 9853937
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis.
    Tang G, Yin W, Cao Y, Tan L, Wu S, Cao Y, Fu X, Yan J, Jiang X.
    Hum Vaccin Immunother; 2018 Dec 04; 14(11):2636-2643. PubMed ID: 29985751
    [Abstract] [Full Text] [Related]

  • 18. Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.
    Bandyopadhyay AS, Gast C, Rivera L, Sáez-Llorens X, Oberste MS, Weldon WC, Modlin J, Clemens R, Costa Clemens SA, Jimeno J, Rüttimann R.
    Lancet Infect Dis; 2021 Apr 04; 21(4):559-568. PubMed ID: 33284114
    [Abstract] [Full Text] [Related]

  • 19. [Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].
    Lu L, Li XM, Liu DL, Zhang HR, Zhang ZJ, Wang HH, Liu F, Ning ZQ, Zhang LW, Chu P, Xie YT, Xu Y, Li J, Pang XH, Deng Y.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun 04; 46(6):510-3. PubMed ID: 22943896
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.